CONMED CORPORATION (NASDAQ:CNMD)’S DIRECTOR CHARLES FARKAS BOUGHT 292 SHARES OF THE COMPANY
By Kenneth Eby
Conmed Corp director and an insider Charles Farkas in the last few days paid for 292 company shares having a worth of $13,939 at the average share price of $47.7. This deal decreased his ownership of the company to 0.01% total market cap or 3,732 shares.
Conmed Corp Sentiment and Fundamentals
The seven security analysts who dissected Conmed Corp’s earnings potential, indicated an earnings per share of $1.83 and a price to earnings ratio of 25.80. They further expect Conmed Corp EPS to growth year-on-year by over 14.25%.
Even though this insider’s acquisition is significant, Octafinance rate the stock NEUTRAL, as our well-know equities trend-following model is not giving a Buy. Conmed Corp’s stock price declined by 10.87% in the last 200 days and is still going downwards.
